Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study

Author:

Doskaliuk BohdanaORCID,Ravichandran NaveenORCID,Sen ParikshitORCID,Day JessicaORCID,Joshi MrudulaORCID,Nune ArvindORCID,Nikiphorou ElenaORCID,Saha SreoshyORCID,Tan Ai LynORCID,Shinjo Samuel KatsuyukiORCID,Ziade NellyORCID,Velikova TsvetelinaORCID,Milchert MarcinORCID,Jagtap KshitijORCID,Parodis IoannisORCID,Gracia-Ramos Abraham EdgarORCID,Cavagna LorenzoORCID,Kuwana MasatakaORCID,Knitza JohannesORCID,Chen Yi MingORCID,Makol AshimaORCID,Agarwal VishweshORCID,Patel Aarat,Pauling John D.ORCID,Wincup ChrisORCID,Barman BhupenORCID,Tehozol Erick Adrian ZamoraORCID,Serrano Jorge RojasORCID,La Torre Ignacio García-DeORCID,Colunga-Pedraza Iris J.ORCID,Merayo-Chalico JavierORCID,Chibuzo Okwara CelestineORCID,Katchamart WanruchadaORCID,Goo Phonpen AkarawatcharanguraORCID,Shumnalieva RusskaORCID,Hoff Leonardo SantosORCID,Kibbi Lina ElORCID,Halabi HusseinORCID,Vaidya BinitORCID,Shaharir Syahrul SazliyanaORCID,Hasan A. T. M. TanveerORCID,Dey DzifaORCID,Gutiérrez Carlos Enrique ToroORCID,Caballero-Uribe Carlo V.ORCID,Lilleker James B.ORCID,Salim BaburORCID,Gheita TamerORCID,Chatterjee TulikaORCID,Distler OliverORCID,Saavedra Miguel A.ORCID,Kardes Sinan,Andreoli Laura,Lini Daniele,Schreiber Karen,Vince Melinda Nagy,Singh Yogesh Preet,Ranjan Rajiv,Jain Avinash,Pandya Sapan C.,Pilania Rakesh Kumar,Sharma Aman,M Manesh Manoj,Gupta Vikas,Kavadichanda Chengappa G.,Patro Pradeepta Sekhar,Ajmani Sajal,Phatak Sanat,Goswami Rudra Prosad,Chowdhury Abhra Chandra,Mathew Ashish Jacob,Shenoy Padnamabha,Asranna Ajay,Bommakanti Keerthi Talari,Shukla Anuj,Pande Arunkumar R.,Chandwar Kunal,Ghodke Akanksha,Boro Hiya,Fazal Zoha Zahid,Cansu Döndü Üsküdar,Yıldırım Reşit,Del PapaSambataro Armen Yuri Gasparyan Nicoletta Gian,Fabiola Atzeni,Parisi Marcello Govoni Simone,Bocci Elena Bartoloni,Sebastiani Gian Domenico,Fusaro Enrico,Quartuccio Marco Sebastiani Luca,Franceschini Franco,Orsolini Pier Paolo Sainaghi Giovanni,De AngelisVenerito Rossella Maria Giovanna Danielli Vi,Grignaschi Silvia,Giollo Alessandro,Alluno Alessia,Ioannone Florenzo,Fornaro Marco,Traboco Lisa S.,Wibowo Suryo Anggoro Kusumo,Loarce-Martos Jesús,Prieto-González Sergio,Gonzalez Raquel Aranega,Yoshida Akira,Nakashima Ran,Sato Shinji,Kimura Naoki,Kaneko Yuko,Gono Takahisa,Tomaras Stylianos,Proft Fabian Nikolai,Holzer Marie-Therese,Gromova Margarita Aleksandrovna,Aharonov Or,Griger Zoltán,Hmamouchi Ihsane,bouchti Imane El,Baba Zineb,Giannini Margherita,Maurier François,Campagne Julien,Meyer Alain,Langguth Daman,Limaye Vidya,Needham Merrilee,Srivastav Nilesh,Landon-Cardinal Marie Hudson Océane,Zuleta Wilmer Gerardo Rojas,Cajas Álvaro Arbeláez Javier,Silva José António Pereira,Fonseca João Eurico,Bohdana Olena Zimba Doskaliuk,Ima-Edomwonyi Uyi,Dedeke Ibukunoluwa,Airenakho Emorinken,Madu Nwankwo Henry,Yerima Abubakar,Olaosebikan Hakeem,A. Becky,Koussougbo Oruma Devi,Palalane Elisa,So Ho,Ugarte-Gil Manuel Francisco,Chinchay Lyn,Bernaola José Proaño,Pimentel Victorio,Fathi Hanan Mohammed,Mohammed Reem Hamdy A.,Harifi Ghita,Cabriza Yurilís Fuentes-Silva Karoll,Losanto Jonathan,Colaman Nelly,Cachafeiro-Vilar Antonio,Bautista Generoso Guerra,Ho Enrique Julio Giraldo,Nunez Lilith Stange,M Cristian Vergara,Báez Jossiell Then,Alonzo Hugo,Pastelin Carlos Benito Santiago,Salinas Rodrigo García,Obiols Alejandro Quiñónez,Chávez Nilmo,Ordóñez Andrea Bran,Llerena Gil Alberto Reyes,Sierra-Zorita Radames,Arrieta Dina,Hidalgo Eduardo Romero,Saenz Ricardo,M Idania Escalante,Calapaqui Wendy,Quezada Ivonne,Arredondo Gabriela,Chinoy HectorORCID,Agarwal VikasORCID,Aggarwal RohitORCID,Gupta LatikaORCID,

Abstract

AbstractLimited evidence on long-term COVID-19 vaccine safety in patients with idiopathic inflammatory myopathies (IIMs) continues to contribute to vaccine hesitancy. We studied delayed-onset vaccine adverse events (AEs) in patients with IIMs, other systemic autoimmune and inflammatory disorders (SAIDs), and healthy controls (HCs), using data from the second COVID-19 Vaccination in Autoimmune Diseases (COVAD) study. A validated self-reporting e-survey was circulated by the COVAD study group (157 collaborators, 106 countries) from Feb–June 2022. We collected data on demographics, comorbidities, IIM/SAID details, COVID-19 history, and vaccination details. Delayed-onset (> 7 day) AEs were analyzed using regression models. A total of 15165 respondents undertook the survey, of whom 8759 responses from vaccinated individuals [median age 46 (35–58) years, 74.4% females, 45.4% Caucasians] were analyzed. Of these, 1390 (15.9%) had IIMs, 50.6% other SAIDs, and 33.5% HCs. Among IIMs, 16.3% and 10.2% patients reported minor and major AEs, respectively, and 0.72% (n = 10) required hospitalization. Notably patients with IIMs experienced fewer minor AEs than other SAIDs, though rashes were expectedly more than HCs [OR 4.0; 95% CI 2.2–7.0, p < 0.001]. IIM patients with active disease, overlap myositis, autoimmune comorbidities, and ChadOx1 nCOV-19 (Oxford/AstraZeneca) recipients reported AEs more often, while those with inclusion body myositis, and BNT162b2 (Pfizer) recipients reported fewer AEs. Vaccination is reassuringly safe in individuals with IIMs, with AEs, hospitalizations comparable to SAIDs, and largely limited to those with autoimmune multimorbidity and active disease. These observations may inform guidelines to identify high-risk patients warranting close monitoring in the post-vaccination period.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3